CNTNHealthcare · Biotechnology

CNTN Stock Forecast: Canton Strategic Holdings, Inc. Price Predictions for 2026-2027

Last close, 29 Oct 2026

$2.05

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 12 of 100 as at 29 Oct 2026 — in the weakest quartile.

Market cap

$163.3M

Ticker Nerd rank

12/ 100

Median analyst target

—

Analysts covering

—

Revenue$1.5M

Operating income−$1.2M

Net income−$19.3M

Free cash flow−$7.0M

Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown

Ticker Nerd rank

CNTN stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Canton Strategic Holdings, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 29 Oct 2026

12/ 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Size

Momentum

Quality

Volatility

Growth

Revisions

Issuance

Accruals

Value

Size (69): Smaller than most of the companies we track.

Value (5): The shares cost a lot relative to the profits and assets behind them.

Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.

Wall Street

CNTN stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on CNTN, reported as data — targets and ratings, the market's view beside the model's.

We don’t hold enough price history for this company yet.

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

CNTN appears in the Radar on the weeks it earns a place.

Market Radar, every Monday: the week's biggest rank moves across ~4,600 US stocks, and the reason for each.
The AI build-out map, free: every AI company we track, part by part, and one part in full with each verdict.

The AI build-out map

PDF

AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and serversIn full
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST

Estimates

CNTN analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

Canton Strategic Holdings, Inc. (CNTN) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation

Trailing P/E: −1.8×
Price / sales: 108.7×
Price / book: 0.3×
EV / EBITDA: −5.7×

Growth & margins

Revenue growth (YoY): —
Earnings growth (YoY): —
Gross margin: —
Operating margin: −80.4%
Net margin: 0.0%

Returns & dividend

Return on equity: −42.2%
Return on assets: −11.7%
Dividend yield: 0.0%

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Canton Strategic Holdings, Inc. (CNTN) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

Canton Strategic Holdings, Inc. has a market value of $163.3M and an enterprise value of $114.9M.
Revenue in the twelve months to 30 June 2026: $1.5M.
Net income over the same four quarters: −$98.1M, a −6559.3% net margin.
Free cash flow in the twelve months to 30 June 2026: −$159.3M.
Shares outstanding: 77.3M.
Trailing P/E: −1.8×.
Forward dividend yield: 0.00%, paying out 0% of earnings.
Canton Strategic Holdings, Inc. employs 12 people — $125K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 28 Oct 2026

Data provided by Twelve Data

Peers

CNTN vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelBiotechnology

Company	Market cap	TKN rank
CNTNCanton Strategic Holdings, Inc.	$163.3M	12
CUECue Biopharma, Inc.	$155.8M	30
NGENNervGen Pharma Corp.	$154.8M	22
PDSBPDS Biotechnology Corp.	$162.8M	81
MGNXMacroGenics, Inc.	$151.3M	60
ABOSAcumen Pharmaceuticals, Inc.	$165.4M	62
STROSutro Biopharma, Inc.	$149.8M	74

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Canton Strategic Holdings, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest CNTN news & analysis

Canton Strategic Holdings Announces Intent to Become First Tokenized U.S. Equity

PRNewsWire · 29 Oct 2026positive

Canton Strategic Holdings announced an agreement with TSV LLC to make its common shares available for trading on TSV, a permissioned venue for tokenized NMS stocks on the Canton Network. The proposed tokenized shares would carry the same rights as CNTN shares traded on Nasdaq, with 24/7 trading and atomic settlement.

Why it matters — CNTN watchers may be interested in the company's planned access to tokenized equity trading on the Canton Network.

Canton Strategic Holdings, Inc. Delivers Third Quarter Canton Network Ecosystem Update

PRNewsWire · 14 Oct 2026positive

Canton Strategic Holdings announced the release of its third-quarter 2026 Canton Network ecosystem report, examining governance milestones and continued institutional adoption. The company will discuss the report in a publicly available webinar on October 21, 2026, at 11:00 a.m.

Why it matters — CNTN watchers may find the report and webinar relevant for updates on governance and institutional adoption within the Canton Network ecosystem.

Canton Strategic Holdings, Inc. Releases Second Quarter 2026 Financial and Operational Results

PRNewsWire · 14 Aug 2026positive

Canton Strategic Holdings reported its financial and operating results for the second quarter ended June 30, 2026, recording its first operating revenue from locking service and Super Validator operations while completing the sale of its legacy biotechnology subsidiary Gravitas. The announcement was made via press release on August 14, 2026.

Why it matters — This marks the company's first meaningful operating revenue from its core Canton Coin-related operations and completes its exit from the biotechnology business, reflecting a shift toward its digital asset strategy.

Canton Strategic: Highly Intriguing Blockchain Treasury With Tangible Risks

Seeking Alpha · 6 Aug 2026neutral

Canton Strategic Holdings, Inc. has pivoted from biotech into a pure-play blockchain treasury centered on Canton Coin and Super Validator operations, targeting institutional adoption and privacy-focused blockchain solutions. Despite operational progress and some institutional backing, CNTN remains pre-revenue, loss-making, and exposed to regulatory, custodial, and adoption risks.

Why it matters — A CNTN watcher would care because the company's full pivot into a blockchain treasury model documents both its strategic repositioning and the unresolved risks that will shape its viability.

Three New Directors Elected to the Board of Canton Strategic Holdings, Inc.

PRNewsWire · 28 July 2026positive

Canton Strategic Holdings, Inc. announced that Sean Galvin, Pamela L. Carter, and Rishi Nangalia were elected as directors to its Board of Directors, effective July 13, 2026, following the Company's Annual Shareholder Meeting.

Why it matters — A CNTN watcher would care because the appointments are described as strengthening governance as the Company advances its Canton Network strategy.

FAQ

Frequently asked questions about CNTN stock

How does Ticker Nerd's model rank CNTN?

As at 29 Oct 2026, Canton Strategic Holdings, Inc. ranks 12 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (69 of 100).

What is the CNTN stock forecast for 2030?

No analyst covering Canton Strategic Holdings, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CNTN are extrapolating price history, which says nothing about the business.

What does Canton Strategic Holdings, Inc. do?

What is the latest news on CNTN?

The most recent item we track (PRNewsWire, 29 Oct 2026): "Canton Strategic Holdings Announces Intent to Become First Tokenized U.S. Equity". Canton Strategic Holdings announced an agreement with TSV LLC to make its common shares available for trading on TSV, a permissioned venue for tokenized NMS stocks on the Canton Network. The proposed tokenized shares would carry the same rights as CNTN shares traded on Nasdaq, with 24/7 trading and atomic settlement.

Company

About Canton Strategic Holdings, Inc.

Canton Strategic Holdings, Inc. is a U.S.-based public company focused on two distinct operating areas: digital asset treasury activities tied to the Canton Network and clinical-stage biotechnology research and development. The company works to support institutional blockchain adoption through the use of Canton Coin, network validation, and ecosystem participation, helping enable the digitization of financial market infrastructure. Alongside its blockchain-related activities, Canton Strategic Holdings maintains a biotechnology segment centered on developing therapeutic candidates for inflammation, immunology, and other specialized medical conditions. Its business model combines participation in emerging digital asset infrastructure with life sciences research, giving it a position at the intersection of financial technology and biotechnology. Canton Strategic Holdings, Inc. is headquartered in Red Bank, New Jersey.

CEO Mr. Mark Wendland · 12 employees · United States · https://www.cantonstrategic.com